Back

Empagliflozin restores autophagy and ameliorates ponatinib-induced cardiomyocyte death

27 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Clinical pharmacology Cardiotoxicity of Drugs ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Associate Professor Giuseppina Novo

University of Palermo, Palermo (Italy)

7 More presentations in this session

Presentation thumbnail
Temporal trends of first time antihypertensive treatment among citizens over 75 years - a register-based, cohort study
Mr S. Nielsen (Hellerup, DK)
Abstract Slides Video
Presentation thumbnail
Targeting liver angiotensinogen using a GalNAc-siRNA improves cardiac remodeling in spontaneously hypertensive rats
Doctor J. Wikstrom (SE)
Abstract Slides Video
Presentation thumbnail
RAAS inhibitors in patients undergoing transcatheter aortic valve implantation: insights from the EffecTAVI registry
Doctor C. Basile (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Amiodarone induced thyroid dysfunction.
Doctor P. Gudjonsson (Reykjavik, IS)
Abstract Slides Video
Presentation thumbnail
Xanthine oxidase inhibitors withdrawal syndrome
Doctor M. Kuwabara (Shimotsuke, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical pharmacology

The Event

Event poster

ESC Congress 2023

27 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of SGLT2i empagliflozin on left ventricular and mitochondrial function in a porcine model of anthracycline-induced cardiotoxicity
20 May 2023
thumbnail
Congress Presentation
Circulating markers of autophagy dysfunction are associated with coronary artery disease in patients undergoing coronary angiography
1 September 2025
thumbnail
Congress Presentation
Direct effects of the tyrosine kinase inhibitors (TKIs) nilotinib and imatinib on the myocardium: clues towards cardiotoxic profiles
20 June 2025
thumbnail
Congress Presentation
Empaglifozin modifies the arterial stiffness in type-2 diabetic patients: a preliminary report
13 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources